Dallas (1)

Duarte (1)

Scottsdale (1)

Recurrent Hepatocellular Carcinoma (1)

Refractory Liver Carcinoma (1)

Stage IV Hepatocellular Carcinoma AJCC v8 (1)

Stage IVA Hepatocellular Carcinoma AJCC v8 (1)

Stage IVB Hepatocellular Carcinoma AJCC v8 (1)

Active, not recruiting (1)

phase 1 (1)

City of Hope Medical Center (1)

National Cancer Institute (NCI) (1)

cyclophosphamide (1)

cytokine-based biologic agent irx-2 (1)

nivolumab (1)

biological (1)

drug (1)

Other (1)

Interventional (1)

refractory liver carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Oct 7, 2022